OPPENHEIMER ASSET MANAGEMENT INC. - PORTOLA PHARMACEUTICALS INC ownership

PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 166 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 3.71 and the average weighting 0.4%.

Quarter-by-quarter ownership
OPPENHEIMER ASSET MANAGEMENT INC. ownership history of PORTOLA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$186,000
-74.2%
26,200
-13.2%
0.01%
-66.7%
Q4 2019$721,000
-19.7%
30,196
-9.8%
0.02%
-25.0%
Q3 2019$898,000
+11.4%
33,483
+12.8%
0.02%
+11.1%
Q2 2019$806,000
-28.8%
29,693
-9.0%
0.02%
-28.0%
Q1 2019$1,132,000
+616.5%
32,634
+303.8%
0.02%
+525.0%
Q4 2018$158,000
-31.6%
8,081
-6.6%
0.00%
-20.0%
Q3 2018$231,000
+0.4%
8,655
+42.4%
0.01%
-16.7%
Q2 2018$230,000
+48.4%
6,079
+112.4%
0.01%
+50.0%
Q3 2017$155,000
+237.0%
2,862
+251.2%
0.00%
+300.0%
Q2 2017$46,000
+12.2%
815
-22.7%
0.00%0.0%
Q1 2017$41,0001,0550.00%
Other shareholders
PORTOLA PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Fernwood Investment Management, LLC 232,952$5,498,0005.39%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,673,727$86,700,0003.41%
Redmile Group, LLC 1,466,537$34,610,0003.31%
SECTORAL ASSET MANAGEMENT INC 1,229,382$29,013,0003.00%
HARVEY CAPITAL MANAGEMENT INC 206,530$4,874,0002.44%
Marcus Capital, LLC 75,150$1,774,0001.87%
Cormorant Asset Management, LP 396,000$9,346,0001.32%
Rail-Splitter Capital Management, LLC 221,414$5,225,0001.25%
Temasek Holdings (Private) Ltd 6,583,568$155,372,0001.21%
EMERALD MUTUAL FUND ADVISERS TRUST 636,526$15,022,0000.84%
View complete list of PORTOLA PHARMACEUTICALS INC shareholders